We Give Shareholders a Voice
Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Rafael Holdings, Inc. (“Rafael Holdings” or the “Company”) (NYSE: RFL) with Rafael Pharmaceuticals, Inc. Under the terms of the merger, Rafael Pharmaceuticals, Inc. will own approximately 48% of the combined company.
The Rafael Holdings merger investigation concerns whether the Board of Rafael Holdings has harmed stockholders by agreeing to enter into this transaction and whether all material facts have been properly disclosed to stockholders.
To receive more information, please fill out the form.